Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HRH3 | Q9Y5N1 | 5/20 | 0.63 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.54 |
| ▸ | HRH2 | P25021 | 1/20 | 0.53 |
| ▸ | HRH1 | P35367 | 1/20 | 0.53 |
| ▸ | MEN1 | O00255 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5296696 | 0.90 | HRH3 (0.74) | HRH3HRH2HRH1 | |
| SCHEMBL491582 | 0.83 | MEN1 (0.69) | HRH3MEN1KMT2A | |
| SCHEMBL7391167 | 0.82 | HRH3 (0.72) | HRH3SLC6A4HRH2HRH1 | |
| SCHEMBL7387065 | 0.81 | ABCB11 (0.50) | HRH3KMT2A | |
| SCHEMBL12741310 | 0.80 | MAOB (0.51) | HRH3 | |
| SCHEMBL5281178 | 0.80 | HRH4 (0.69) | HRH3 | |
| SCHEMBL7422153 | 0.80 | HRH3 (0.58) | HRH3SLC6A4HRH2HRH1 | |
| SCHEMBL491835 | 0.79 | HRH3 (1.00) | HRH3HRH2HRH1MEN1KMT2A | |
| SCHEMBL7391801 | 0.79 | HRH3 (0.78) | HRH3SLC6A4HRH2HRH1 | |
| SCHEMBL5277493 | 0.78 | HRH3 (0.61) | HRH3SLC6A4HRH2HRH1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1863486-A2 | TREATMENT OF EPILEPSY WITH NON-IMIDAZOLE ALKYLAMINES HISTAMINE H3-RECEPTOR LIGANDS | BIOPROJET (FR) | 2007-12-12 | — | — | EP | disclosed |
| WO-2006103537-A2 | TREATMENT OF EPILEPSY WITH NON-IMIDAZOLE ALKYLAMINES HISTAMINE H3-RECEPTOR LIGANDS | BIOPROJET (FR) | 2006-10-05 | — | — | WO | disclosed |